03-Nov-2026 08:29:50
SHARDACROPExpansion
SHARDA CROPCHEM Q2 FY27 CONCALL: MAINTAINS FY27 REVENUE GROWTH OUTLOOK OF 10.3% & 18–20% EBITA MARGIN GUIDANCE; EXPECTS STRONG H2 RECOVERY IN EUROPE, IMPROVING GROSS MARGINS & PLANS ₹550–600 CR FY27 CAPEX
SHARDA CROPCHEM LTD.